title: Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
abstract: OBJECTIVE
  The success of immunotherapy with dendritic cells (DC) to treat cancer is dependent on effective migration to the lymph nodes and subsequent activation of antigen-specific T cells. In this study, we investigated the fate of DC after intradermal (i.d.) or intranodal (i.n.) administration and the consequences for the immune activating potential of DC vaccines in melanoma patients.
  
  
  METHODS
  DC were i.d. or i.n. administered to 25 patients with metastatic melanoma scheduled for regional lymph node resection. To track DC in vivo with scintigraphic imaging and in lymph nodes by immunohistochemistry, cells were labeled with both [(111)In]-indium and superparamagnetic iron oxide.
  
  
  RESULTS
  After i.d. injection, maximally 4% of the DC reached the draining lymph nodes. When correctly delivered, all DC were delivered to one or more lymph nodes after i.n. injection. Independent of the route of administration, large numbers of DC remained at the injection site, lost viability, and were cleared by infiltrating CD163+ macrophages within 48 hours. Interestingly, 87 +/- 10% of the surviving DC preferentially migrated into the T-cell areas, where they induced antigen-specific T-cell responses. Even though more DC reached the T-cell areas, i.n. injection of DC induced similar antigen-specific immune responses as i.d. injection. Immune responses were already induced with <5 x 10(5) DC migrating into the T-cell areas.
  
  
  CONCLUSIONS
  Monocyte-derived DC have high immune activating potential irrespective of the route of vaccination. Limited numbers of DC in the draining lymph nodes are sufficient to induce antigen-specific immunologic responses.
authors.affiliation: Department of Tumor Immunology, Nijmegen Centre for Molecular Life Science, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
authors.forename: Pauline
authors.initials: P
authors.lastname: Verdijk
authors.forename: Erik H J G
authors.initials: EH
authors.lastname: Aarntzen
authors.forename: W Joost
authors.initials: WJ
authors.lastname: Lesterhuis
authors.forename: A C Inge
authors.initials: AC
authors.lastname: Boullart
authors.forename: Ellemieke
authors.initials: E
authors.lastname: Kok
authors.forename: Michelle M
authors.initials: MM
authors.lastname: van Rossum
authors.forename: Simon
authors.initials: S
authors.lastname: Strijk
authors.forename: Femke
authors.initials: F
authors.lastname: Eijckeler
authors.forename: Johannes J
authors.initials: JJ
authors.lastname: Bonenkamp
authors.forename: Joannes F M
authors.initials: JF
authors.lastname: Jacobs
authors.forename: Willeke
authors.initials: W
authors.lastname: Blokx
authors.forename: J Han J M
authors.initials: JH
authors.lastname: Vankrieken
authors.forename: Irma
authors.initials: I
authors.lastname: Joosten
authors.forename: Otto C
authors.initials: OC
authors.lastname: Boerman
authors.forename: Wim J G
authors.initials: WJ
authors.lastname: Oyen
authors.forename: Gosse
authors.initials: G
authors.lastname: Adema
authors.forename: Cornelis J A
authors.initials: CJ
authors.lastname: Punt
authors.forename: Carl G
authors.initials: CG
authors.lastname: Figdor
authors.forename: I Jolanda M
authors.initials: IJ
authors.lastname: de Vries